EVATAR - A Female Reproductive Tract on a Chip

Article

We spoke to Dr. J. Julie Kim, Northwestern University, to learn more about the EVATAR project and how it could help the future of drug discovery and personalized medicine.

Read more

Novel Tools for Cellular Biomechanics

Life In Science

Dr. Wan tells us about his career and the work his lab is doing to advance understanding of cellular biomechanics using microfluidics.

Read more

Simplify Your 3D Cell Culture with a Novel Method for Tissue Modeling

Video

This video shows the technology behind the RAFT™ 3D Cell Culture System and how it creates high-density collagen scaffolds with cells embedded. The RAFT™ System has successfully been used in many research areas including toxicology, oncology, blood brain barrier models, corneal models and more. Coming along with easy-to-follow protocols, RAFT™ System allows you to set up robust 3D cultures in less than an hour. Learn more about RAFT™ System on www.lonza.com/raft-3d-culture.com.

Watch Now
Animal Model For Rare Brain Disease H-ABC Found

Animal Model For Rare Brain Disease H-ABC Found

News

Professor Ian Duncan describes his 29-year quest to understand the root-cause of a brain disease he identified in rats, and in doing so has found the link to a fatal and rare childhood brain disease in humans, H-ABC. Meaning the development of a cure is now possible.

Read more
 
Antisense Oligonucleotide Shows Promise in Treatment of ALS and Spinocerebellar Ataxia Type 2
News

Two teams investigated whether an antisense oligonucleotide drug that turns off the ATXN2 gene could be used as a potential therapy in mouse models of these diseases.

Read more

Enamine, EMBL Partner on Cancer Drug Discovery Research
News

A strategic agreement between Europe’s flagship laboratory for basic research in molecular biology and the world’s largest medicinal chemistry design house.

Read more

SYGNIS, TANON Extend Collaboration
News

The current OEM agreement is expanded to cover two additional product lines, with an expected annual revenue contribution now more than EUR 1M.

Read more